BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12682336)

  • 1. Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease.
    Kanno H; Yamamoto I; Yoshida M; Kitamura H
    Neurology; 2003 Apr; 60(7):1197-9. PubMed ID: 12682336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
    Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
    Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
    Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
    J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report.
    Tibbs RE; Bowles AP; Raila FA; Fratkin JD; Hutchins JB
    Neurosurgery; 1997 Apr; 40(4):848-55; discussion 855. PubMed ID: 9092862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization.
    Sprenger SH; Gijtenbeek JM; Wesseling P; Sciot R; van Calenbergh F; Lammens M; Jeuken JW
    J Neurooncol; 2001 May; 52(3):241-7. PubMed ID: 11519854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple intracerebral haemangioblastomas in identical twins with von Hippel-Lindau disease--a clinical and molecular study.
    Sobottka SB; Frank S; Hampl M; Schackert HK; Schackert G
    Acta Neurochir (Wien); 1998; 140(3):281-5. PubMed ID: 9638266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
    Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
    Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suprasellar hemangioblastoma in a patient with von Hippel-Lindau disease confirmed by germline mutation study: case report and review of the literature.
    Goto T; Nishi T; Kunitoku N; Yamamoto K; Kitamura I; Takeshima H; Kochi M; Nakazato Y; Kuratsu J; Ushio Y
    Surg Neurol; 2001 Jul; 56(1):22-6. PubMed ID: 11546565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
    Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrous meningioma in a patient with von Hippel-Lindau disease: a genetic analysis.
    Governale LS; Vortmeyer AO; Zhuang Z; Oldfield EH
    J Neurosurg; 2001 Dec; 95(6):1045-9. PubMed ID: 11765821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis.
    Decker HJ; Weidt EJ; Brieger J
    Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion.
    Vortmeyer AO; Huang SC; Pack SD; Koch CA; Lubensky IA; Oldfield EH; Zhuang Z
    Oncogene; 2002 Feb; 21(8):1167-70. PubMed ID: 11850836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
    Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
    Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
    Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
    Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastases to hemangioblastomas in von Hippel-Lindau disease.
    Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
    J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.